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MaBACKGROUND Measuring quality of life (QOL) is fundamental to understanding the impact of disease and treatment
on patients’ lives.
OBJECTIVES This study aimed to explore QOL in an international sample of adults with congenital heart disease (CHD),
the association between patient characteristics and QOL, and international variation in QOL and its relationship to
country-speciﬁc characteristics.
METHODS We enrolled 4,028 adults with CHD from 15 countries. QOLwas assessed using a linear analog scale (LAS) (0 to
100)and theSatisfactionwithLifeScale (SWLS) (5 to35). Patient characteristics includedsex, age,marital status, educational
level, employment status, CHD complexity, and patient-reported New York Heart Association (NYHA) functional class.
Country-speciﬁc characteristics included general happiness and 6 cultural dimensions. Linear mixed models were applied.
RESULTS Median QOL was 80 on the LAS and 27 on the SWLS. Older age, lack of employment, no marriage history, and
worse NYHA functional class were associated with lower QOL (p < 0.001). Patients from Australia had the highest QOL
(LAS: 82) and patients from Japan the lowest (LAS: 72). Happiness scores and cultural dimensions were not associated
with variation in QOL after adjustment for patient characteristics and explained only an additional 0.1% of the variance
above and beyond patient characteristics (p ¼ 0.56).
CONCLUSIONS This large-scale, international study found that overall QOL in adults with CHD was generally good.
Variation in QOL was related to patient characteristics but not country-speciﬁc characteristics. Hence, patients at risk for
poorer QOL can be identiﬁed using uniform criteria. General principles for designing interventions to improve QOL can be
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2238L iving well is as important to mostpeople as living longer. Therefore,the concept of quality of life (QOL)
has gained much attention in biomedical sci-
ence over the past few decades (1,2). In this
respect, comprehensive assessments of QOL
and other patient-reported outcomes
(PROs) have become indispensable (1–4).
PROs are descriptions coming directly from
patients about how they feel or function in
relation to their health and well-being (5),
and have been associated with important
medical outcomes (6). Although the cardiol-
ogy community recognizes that it is impera-
tive to assess PROs to better understandthe impact of health and disease, these outcomes
remain underused in cardiovascular clinical
trials (7). Moreover, many studies on PROs in the
larger ﬁeld of chronic diseases use poor-quality in-
struments (8).SEE PAGE 2246In the cardiac subspecialty of congenital heart
disease (CHD), QOL research commenced 40 years
ago and has increased exponentially over time (9). To
date, more than 230 QOL studies in CHD conducted in
35 countries have been published (9). However, a
critical appraisal revealed that most articles on QOL
had substantial conceptual and methodological deﬁ-
cits (9), yielding inconsistent results (10,11). Such
inconsistencies may be attributable to differences
in methodological approaches or to genuine differ-
ences in QOL between patients living in different
countries (12). Furthermore, these studies investi-
gated only demographic and/or medical predictors of
QOL, leaving population measures or cultural di-
mensions unaddressed. It is reasonable to hypothe-
size that QOL scores among adults with CHD might
be higher in countries known to have higher QOL
in the general population (e.g., Denmark, Norway, or
Switzerland). This possibility, however, has never
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received January 14, 2016; accepted March 2, 2016.To gain a better understanding of QOL in patients
with CHD worldwide, it is critical to examine QOL
in different countries using a uniform research meth-
odology. This allows us to ascertain whether there are
genuine differences in QOL in patients living in
different countries, independent of methodological
considerations. Furthermore, it enables us to evaluate
whether country-speciﬁc characteristics explain QOL
above and beyond patient characteristics. Therefore,
the aims of this study were to: 1) describe QOL in a
large international sample of adults with CHD; 2)
investigate the association between QOL and patient
characteristics (i.e., sociodemographic and medical
variables); and 3) explore variation in QOL across
countries and investigate the relationship between
QOL and country characteristics (i.e., general popula-
tion happiness and cultural dimensions).
METHODS
We established an international collaborative
research group and undertook APPROACH-IS
(Assessment of Patterns of Patient-Reported Out-
comes in Adults with Congenital Heart disease – In-
ternational Study). APPROACH-IS is a cross-sectional,
multilevel study with a standardized protocol con-
ducted in partnership with the International Society
for Adult Congenital Heart Disease (12). Data were
collected in 15 countries from 5 continents: Argentina,
Australia, Belgium, Canada, France, India, Italy,
Japan, Malta, Norway, Sweden, Switzerland, Taiwan,
the Netherlands, and the United States. The study
was approved by the institutional review board of the
University Hospitals Leuven/KU Leuven Belgium (the
coordinating center) and the local institutional re-
view board of participating centers when required. All
subjects provided written informed consent to
participate. Detailed information on the rationale,
design, and methods is available in a published
methods paper (12).
STUDY POPULATION AND PROCEDURE. A question-
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2239clinic to patients with CHD. Data collection ran from
April 2013 to March 2015. Inclusion criteria were: 1)
diagnosis of CHD, deﬁned as a structural abnormality
of the heart or intrathoracic great vessels that is present
at birth and of actual or potential functional signiﬁ-
cance (13); 2) 18 years of age or older; 3) diagnosis
established before adolescence; 4) continued follow-
up at a CHD center or included in a national/regional
registry; and 5) physical, cognitive, and language
capabilities required to complete self-report ques-
tionnaires. Patients with prior heart transplantation or
primary pulmonary hypertension were excluded (12).
QUALITY OF LIFE. Relying on thorough conceptual
grounds (2), QOL was deﬁned as “the degree of
overall life satisfaction that is positively or negatively
inﬂuenced by individuals’ perception of certain as-
pects of life important to them, including matters
both related and unrelated to health” (14). Using this
conceptualization, QOL refers to a global perspective
and is not limited to health-related factors. Consis-
tent with this deﬁnition, 2 instruments to assess QOL
were administered: a linear analog scale (LAS) and
the Satisfaction with Life Scale (SWLS). A critical
appraisal demonstrated that the use of these 2
instruments produced a more robust score than the
use of other instruments (9).
The LAS is a vertically oriented line that ranges
from 0 (worst imaginable QOL) to 100 (best imagin-
able QOL) (15). The LAS has well-established reli-
ability and validity for adults with CHD (15) and it is
used frequently in medical research (16,17).
The SWLS assesses a person’s global judgment of
life satisfaction and comprises 5 statements with a
response scale ranging from 1 (strongly disagree) to 7
(strongly agree). A score of 20 represents the neutral
point on the scale (18). The SWLS has good psycho-
metric properties (15,19).
PATIENT- AND COUNTRY-SPECIFIC CHARACTERISTICS.
Demographic data including sex, age, marital
status, educational level, employment status, and
patient-reported New York Heart Association (NYHA)
functional class assessment were collected using a
self-report questionnaire. The complexity of patients’
heart defects (simple, moderate, or complex) was
extracted from medical records (12).
Country-speciﬁc data on happiness (i.e., a popu-
lation measure) were drawn from the World Happi-
ness Report 2013 (20). This report presents national
happiness levels based on surveys administered from
2010 through 2012 in 156 countries. More speciﬁcally,
individual respondents in the World Happiness
Report study were asked to evaluate their lives by
imagining life as a ladder, with the best possible lifefor them as a 10 and the worst possible life as a 0 (the
Cantril ladder) (20).
Scores on the dimensions of national culture (scale
from 0 to 100) were based on extensive research
conducted by Hofstede in 76 countries and regions
(21). This validated model includes 6 dimensions: a
power distance index (higher scores reﬂect higher
levels of acceptance that power is distributed un-
equally in society), individualism versus collectivism
(high scores reﬂect individualistic societies), mascu-
linity versus femininity (higher scores reﬂect more
masculine societies directed toward achievement and
success), uncertainty avoidance index (higher scores
reﬂect societies that are more rigid in beliefs and
behaviors), long-term orientation versus short-term
normative orientation (thriftiness and perseverance
are associated with higher scores), and indulgence
versus restraint (higher scores are observed in soci-
eties that foster gratiﬁcation of human drives related
to enjoying life and having fun) (21). Scores on
happiness and cultural dimensions per country are
described in the Online Table 1.
STATISTICAL ANALYSES. Continuous data are pre-
sented as medians and interquartile ranges (IQR).
Categorical variables are presented as absolute
numbers and percentages. The association of patient-
and country-speciﬁc characteristics with QOL was
estimated through general linear mixed models
(GLMM). A 2-level structure, in which patients were
nested within countries, was assumed because dif-
ferences between countries was the focus of this
study. A 3-level model that considers within-country
variations was not feasible computationally given the
large number of countries with only 1 participating
center. Empirical Bayes estimates with 95% conﬁ-
dence intervals for the country-speciﬁc QOL levels
were obtained from the GLMM. A (pseudo) R2 statistic
referred to as R2SAS in Shtatland et al. (22) was derived
from the model chi-square. This measure is an esti-
mate of the percentage explained variance. When
reported for the random country effect or for a set of
ﬁxed predictors, these are similar in spirit as the
semipartial R2 (but still approximations).
Linearity was veriﬁed for continuous predictors
and no deviations were observed. Chi-square and
Mann-Whitney U tests were used to compare vari-
ables between subjects with and without missing
information (data on ﬁle). Given the relatively small
proportion of patients with missing values, multiple
imputation was not used to address missing values as
this would unnecessarily complicate data analysis.
Therefore, only patients for whom full data were
available for all variables of interest (n ¼ 3,777 or
TABLE 1 Demographic and Medical Variables*
No. of Respondents n (%)
Female 4,012 2,115 (52.7)
Median age, yrs 4,021 32.0 (IQR: 25-42)
Background 3,944
Middle-Eastern or Arabic 52 (1.3)
Asian 781 (19.8)
Black or African-American 41 (1.0)
Hispanic or Latino 131 (3.3)
White or Caucasian 2,908 (73.7)
Other 31 (0.8)
Educational level 3,989
Less than high school 223 (5.6)
High school 1,715 (43.0)
College degree 846 (21.2)
University degree 1,205 (30.2)
Employment status 4,005
Part-time or full-time work 2,554 (63.7)
Homemaker or retired 331 (8.3)
Job seeking, unemployed,
or disability
515 (12.9)
Full-time student 327 (8.2)
Other 278 (6.9)
Marital status 4,008
Never married 1,753 (43.7)
Married or living with partner 2,045 (51.0)
Divorced or widowed 204 (5.1)
Other 6 (0.2)
Children (yes) 4,004 1,584 (39.6)
Patient-reported NYHA
assessment
3,927
Class I† 2,109 (53.7)
Class II 1,375 (35.0)
Class III 287 (7.3)
Class IV‡ 156 (4.0)
Complexity of heart defect 4,028
Simple 1,040 (25.8)
Moderate 1,957 (48.6)
Complex 1,031 (25.6)
Values are n (%) unless otherwise indicated. *Total population ¼ 4,028.
†Not limited during physical activities. ‡Unable to be physically active without
experiencing discomfort.
IQR ¼ interquartile range; NYHA ¼ New York Heart Association functional class.
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224093.8%) were included in the GLMM. Data analysis was
performed using SAS software, version 9.2 (SAS
Institute Inc., Cary, North Carolina).
RESULTS
Overall, 4,028 adults with CHD were enrolled in the
study. Characteristics of the total sample are detailed
in Table 1. Patients had a median age of 32 years and
53% were women. The majority of patients had a
white or Caucasian background, had a high school
degree, worked part or full time, were married or
living with a partner, and had no children. With regard
to medical characteristics, 49% had CHD of moderate
complexity and 54% reported they were in NYHA
functional class I (asymptomatic). A detailed
description of patient characteristics per country is
provided in the Online Table 2 showing that, for
example, 19% of patients came from the United States.
AIM 1: OVERALL QOL. For the total sample of par-
ticipants who completed surveys (n ¼ 3,952), the
median QOL on the LAS was 80.0 (IQR: 70 to 90) on a
scale ranging from 0 to 100. Figure 1 displays the
distribution of QOL scores for this sample. There was
large variability in QOL scores, with the majority of
patients (91.2%) reporting a score of >50. More spe-
ciﬁcally, 25.8% of patients had a score between 71
and 80, 27.3% had a score between 81 and 90, and
17.4% had a score between 91 and 100 (Figure 1). The
median QOL score on the SWLS was 27.0 (IQR: 22
to 30) on a scale from 5 to 35 (n ¼ 3,892). Scores on
the LAS and SWLS by country are provided in the
Online Table 2.
AIM 2: ASSOCIATION WITH PATIENT CHARACTERISTICS.
In multivariable GLMM analyses, older age; job
seeking, being unemployed, or disabled; never hav-
ing been married; and higher NYHA functional classes
were associated with worse QOL (p < 0.001) (Table 2).
Sex, educational level, and defect complexity were
not associated with QOL. In all, 21.5% of variation in
QOL was explained in the GLMM. Approximate esti-
mates for the semipartial R2 were 20.0% and 2.8% for
patient characteristics and the country differences,
respectively. A similar pattern of results emerged
with regard to the association with QOL as measured
by the SWLS. For reasons of clarity and to optimize
readability, we report QOL for the LAS only for
aims 2 and 3.
AIM 3: INTERNATIONAL VARIATION IN QOL AND
ASSOCIATION WITH COUNTRY-SPECIFIC CHARAC-
TERISTICS. Figure 1 represents between- and with-
in-country variations in QOL as measured with the
LAS. Countries are ranked in descending order of QOLestimates. Australia had the highest QOL estimate
(82.1) and Japan the lowest (71.6), representing a
quite large gap of 10.5 points. In total, 4 countries had
an estimate of $80, including Australia, Switzerland,
the United States, and Malta. All other countries,
with the exception of Japan, had an estimate of $75.
Important intracountry variations were observed
(Figure 1). Scores between 61 and 100 occurred
frequently in all countries (darker shades of blue),
whereas scores between 0 and 60 occurred in #10% of
patients for the majority of countries (lighter shades
of blue). These results depict how intercountry vari-
ation in QOL was relatively minor compared with
intracountry variation in QOL.
FIGURE 1 QOL in Adults with Congenital Heart Disease
Country
Linear Analog Scale Quality of Life
0-10 11-20 21-30 31-40 41-50 51-60 61-70 71-80 81-90 91-100
Australia 0.0% 0.0% 0.0% 3.0% 3.0% 1.5% 12.9% 20.5% 33.3% 25.8% 82.1 (79.6;84.6)
Switzerland 0.0% 0.4% 0.4% 2.2% 4.4% 6.6% 11.0% 16.9% 31.6% 26.5% 81.4 (79.5;83.2)
USA 0.1% 1.1% 1.5% 1.9% 4.8% 3.7% 10.5% 22.5% 28.2% 25.7% 80.4 (79.3;81.6)
Malta 0.0% 0.9% 0.0% 0.0% 4.3% 5.1% 11.1% 32.5% 34.2% 12.0% 80.1 (77.5;82.8)
the Netherlands 0.4% 0.0% 0.8% 0.4% 0.4% 2.4% 17.3% 37.3% 28.5% 12.4% 79.9 (78.0;81.8)
Sweden 0.9% 0.9% 1.5% 2.6% 3.1% 4.6% 12.6% 20.9% 29.2% 23.7% 79.4 (78.0;80.9)
Argentina 1.2% 0.0% 0.6% 0.0% 3.5% 6.4% 15.0% 30.1% 35.3% 8.1% 79.3 (77.1;81.6)
Italy 0.0% 0.0% 0.0% 3.2% 6.3% 3.2% 12.7% 30.2% 30.2% 14.3% 79.2 (75.9;82.5)
France 0.0% 0.0% 0.0% 2.1% 6.3% 5.3% 17.9% 25.3% 25.3% 17.9% 78.6 (75.8;81.5)
Belgium 0.0% 0.7% 1.1% 1.5% 4.4% 5.5% 16.5% 33.5% 28.3% 8.5% 77.0 (75.2;78.9)
India 1.5% 0.0% 1.0% 2.5% 6.1% 10.6% 19.2% 21.2% 17.7% 20.2% 76.9 (74.8;79.0)
Norway 0.0% 1.2% 1.2% 4.0% 5.2% 6.4% 16.8% 24.3% 23.7% 17.3% 76.9 (74.6;79.1)
Canada 0.8% 0.2% 1.4% 1.6% 4.3% 8.4% 19.9% 28.3% 23.8% 11.5% 76.1 (74.7;77.5)
Taiwan 0.0% 0.4% 1.6% 0.8% 6.8% 9.6% 18.1% 31.3% 24.9% 6.4% 75.6 (73.7;77.5)
Japan 1.6% 2.4% 4.0% 4.0% 8.3% 7.1% 15.4% 24.1% 21.3% 11.9% 71.6 (69.7;73.5)
Total Sample 0.5% 0.7% 1.3% 1.9% 4.6% 5.8% 14.9% 25.8% 27.3% 17.4% 80.0 (70-90)
EB estimate
quality of life 
(95%CI)
Median
quality of life (IQR)
In this heat map showing distribution of quality of life (QOL), countries are ranked in descending order of QOL estimates. These Empirical Bayes (EB)
estimates are derived from the general linear mixed model without adjustment for patient and country-speciﬁc characteristics; based on the linear
analog scale for QOL. Darker shades of blue represent more frequent scores as compared with lighter shades of blue. CI ¼ conﬁdence interval;
IQR ¼ interquartile range.
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2241A weak positive relationship between national
happiness levels and QOL was suggested (Central
Illustration). Univariable analyses showed that this
relationship was not signiﬁcant (p ¼ 0.0624) (Table 3).
For example, India had the lowest score in terms of
happiness from all participating countries, but this
did not correspond with its ranking in terms of
QOL estimates (Central Illustration). Similar ﬁgures
demonstrate weak relationships between QOL and
cultural dimensions (Online Figures 1 to 6). Uni-
variable analyses demonstrated that these relation-
ships were nonsigniﬁcant (Table 3). Adjusted for
patient characteristics, the multivariable GLMM ana-
lyses showed that happiness (p ¼ 0.5563) and cultural
dimensions (p ¼ 0.5552) were not associated with
variation in QOL (Table 3). Indeed, adding happiness
and cultural dimensions only increased the explained
variance by 0.1% (21.6% vs. 21.5%).
DISCUSSION
APPROACH-IS investigated QOL in adults with CHD
in 15 countries on 5 continents using a uniform
approach that included patient- and country-speciﬁccharacteristics. We found that QOL was generally
good with a median score of 80 on the LAS (range:
0 to 100) and a median score of 27 on the SWLS
(range: 5 to 35). Nonetheless, nearly 1 in 10 patients
had a QOL of #50 on the LAS. These ﬁndings indicate
that, as a group, adults with CHD are generally
satisﬁed with their lives; however, a subset of pa-
tients experience impaired QOL. Given the associa-
tion between PROs, such as QOL, and important
medical outcomes (6,23), it is of paramount impor-
tance that health care professionals identify patients
with poor QOL and target interventions accordingly.
Patient characteristics linked with poorer QOL are
older age; job seeking, being unemployed, or
disabled; never having been married; and poorer
NYHA functional class. Knowledge of these patient
characteristics may assist providers in identifying
patients at risk for decreased QOL. However, these
patient characteristics explained a relatively small
proportion of the variability in QOL (<20%). Future
challenges include identifying other inﬂuential fac-
tors. Sex, educational level, and defect complexity
were not related to QOL, indicating that symptoms
experienced by patients (i.e., patient-reported NYHA
TABLE 2 Patient Characteristics as QOL Predictors*
Univariable Models Multivariable Model†
Estimate (SE) p Value Estimate (SE) p Value
Sex 0.0156 0.1938
Men 1.3 (0.5) 0.6 (0.5)
Women # #
Age -0.1 (0.02) <0.001 -0.1 (0.03) <0.001
Educational level <0.001 0.7482
Less than high school -7.1 (1.2) <0.001 -1.1 (1.2) 0.3443
High school -2.9 (0.6) <0.001 0.1 (0.6) 0.8471
College degree -0.8 (0.8) 0.3195 -0.1 (0.7) 0.8440
University degree # #
Employment status <0.001 <0.001
Part-time or full-time work -1.2 (1.03) 0.2346 #
Homemaker or retired -5.6 (1.3) <0.001 -0.4 (1.0) 0.7284
Job seeking, unemployed,
or disability
-14.8 (1.2) <0.001 -7.5 (0.8) <0.001
Full-time student -1.6 (1.3) 0.2186 0.1 (1.0) 0.9374
Other # 2.0 (1.0) 0.0411
Marital status 0.0002 <0.001
Never married -7.1 (6.7) 0.2921 -2.6 (0.6) <0.001
Married or living with partner -5.5 (6.7) 0.4141 #
Divorced or widowed -10.0 (6.8) 0.1430 1.6 (1.1) 0.1698
Other # 0.01 (7.4) 0.9986
Patient-reported NYHA assessment <0.001 <0.001
Class I‡ 27.9 (1.3) <0.001 24.1 (1.3) <0.001
Class II 20.9 (1.3) <0.001 17.9 (1.3) <0.001
Class III 10.3 (1.5) <0.001 9.6 (1.5) <0.001
Class IV§ # #
Disease complexity 0.0001 0.9685
Simple 3.0 (0.8) <0.001 -0.2 (0.7) 0.8241
Moderate 2.3 (0.6) 0.0005 -0.02 (0.6) 0.9682
Complex # #
*Results from general linear mixed models (GLMMs) with patient characteristics as predictors for quality of life
(QOL) using the linear analog scale (LAS) in adults with congenital heart disease (n ¼ 3,777). †Total explained
variability derived from the chi-square statistic: 21.5%. Random country effect: chi-square ¼ 106.2 (p < 0.001);
explained variability by country derived from the chi-square statistic: 2.8%. Results based on the LAS for QOL.
‡Not limited during physical activities. §Unable to be physically active without experiencing discomfort.
#Reference category.
Abbreviations as in Table 1.
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2242assessment) were more important contributory fac-
tors to QOL than defect complexity. On an interna-
tional scale, these results conﬁrmed earlier ﬁndings
that QOL is related marginally to the severity of the
heart defect (objective criterion) and more strongly
correlated with illness perceptions and appraisal of
functional status (subjective criteria) (14,24,25).
Therefore, patients with complex CHD might report a
good QOL, particularly if they do not experience
functional impediments or symptoms on a day-to-day
basis (26).
Findings from our study demonstrated that QOL in
adults with CHD varied across countries. This inter-
national variation in QOL remained after adjustment
for patient- and country-speciﬁc characteristics.
Although a few points separated most countries, a>10-point difference in adjusted QOL for countries at
either end of the spectrum (i.e., Australia and Japan)
suggests that further investigation of explanatory
factors is warranted (e.g., workload, income, percep-
tions of people with chronic illnesses, response
patterns, and willingness to endorse poorer QOL
on surveys).
Investigating the potential impact of country-
speciﬁc characteristics represents a new approach in
clinical QOL research, reﬂecting an important addi-
tion to the assessment of patient-related factors.
Indeed, most studies on QOL are oriented toward
demographic and/or medical variables (11) and
neglect population measures, although QOL is also
shaped by cultural characteristics (27). Prior studies
in nonmedical populations have shown that culture
can inﬂuence how individuals report their life satis-
faction (27,28). Japanese and Taiwanese students,
for example, were less likely to use extremes of a
life satisfaction response scale as compared with
American students (29). This phenomenon was not
observed in the present study, as shown in the heat
map (Figure 1). Against our expectations, national
happiness level and cultural dimensions were not
associated with QOL variation in the present study,
after adjustment for patient characteristics. This
implied that adults with CHD at risk for poor QOL can
be identiﬁed using the same criteria, irrespective of
their country of residence. Furthermore, general
principles can be developed to design interventions
to improve QOL. Nonetheless, future work should
examine other country-speciﬁc characteristics that
may account for variation in QOL between nations,
such as health care system factors like access to care
(30,31).
STUDY LIMITATIONS. This study had extensive
power because of the large sample size. Indeed, no
previous survey on QOL in CHD had incorporated
more than 4,000 patients and encompassed 5 conti-
nents. The number of missing values on all variables
of interest was low (data on ﬁle), which minimized
the potential impact of missing data on obtained re-
sults. Third, measurement of QOL was based on a
solid conceptualization, which was lacking in several
previous studies (8,9). The LAS and the SWLS were
utilized to assess QOL. These instruments have been
used previously in different countries and their use
was associated with higher quality scores (9).
Although we only reported results on inferential sta-
tistics with regard to the LAS, an analogous pattern of
results emerged for the SWLS. Hence, our conclusions
are based on a single-item QOL measure, but can be
extended to the multiple-item SWLS. Indeed, prior
CENTRAL ILLUSTRATION QOL and National Happiness Levels per Country
Apers, S. et al. J Am Coll Cardiol. 2016;67(19):2237–45.
In this study, quality of life (QOL) in adults with congenital heart disease was estimated using empirical Bayes estimates derived from the general linear mixed model
without adjusting for patient and country-speciﬁc characteristics and are based on the linear analog scale for QOL. When compared with the national happiness levels
based on the World Happiness Report 2013, a weak positive relationship was suggested between the 2, although the relationship was not statistically signiﬁcant.
TABLE 3 Country-Speciﬁc Characteristics as Additional QOL Predictors*
Univariable Models Multivariable Model†
Estimate (SE) p Value Estimate (SE) p Value
National happiness levels‡ (0-10) 0.5 (1.0) 0.0624 1.2 (2.1) 0.5563
Cultural dimensions§ (0-100) 0.5552k
Power distance index -0.03 (0.1) 0.5513 0.1 (0.1) 0.5636
Individualism vs. collectivism 0.01 (0.04) 0.7928 -0.1 (0.1) 0.3385
Masculinity vs. femininity -0.02 (0.03) 0.5611 -0.004 (0.03) 0.9052
Uncertainty avoidance index -0.01 (0.04) 0.7032 -0.01 (0.04) 0.7367
Long-term orientation vs. short-term
normative orientation
-0.05 (0.03) 0.0914 -0.1 (0.04) 0.0306
Indulgence vs. restraint 0.04 (0.05) 0.4232 -0.02 (0.1) 0.8218
*Results from GLMMs with country-speciﬁc characteristics as additional QOL predictors (LAS) in adults with
congenital heart disease (n ¼ 3,777). †The multivariable model also contains all patient characteristics included in
Table 2 as predictors, but results are reported only for country-speciﬁc characteristics. Total explained variability
derived from the chi-square statistic: 21.6%; random country effect: chi-square ¼ 63.9 (p < 0.001); explained
variability by country derived from the chi-square statistic: 1.7%. ‡Based on the World Happiness Report 2013.
§Based on dimensions of national culture by Hofstede. kp value based on chi-square statistic (likelihood-ratio
test with 6 degrees of freedom) to test any effect of the 6 cultural dimensions. Results based on the LAS for QOL.
Abbreviations as in Tables 1 and 2.
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2243research showed that single-item life satisfaction
measures perform similarly compared with a multiple
item instrument (32).
For most participating countries, data from only 1
center were available. Although some participating
centers are national reference centers accommoda-
ting patients from all over the country, this might
hamper the representativeness. As a result, it was not
possible to distinguish between variations between
centers and countries. Second, we did not collect data
on QOL from a control group. Future studies should
explore differences between QOL in patients and
controls from an international perspective. Indeed, it
might be possible that differences between patients
and controls in the respective countries are mainly
due to the variation in QOL in the general population,
rather than in the patient group. It is possible that
selection bias could affect the results. Because of the
PERSPECTIVES
COMPETENCY IN SYSTEMS-BASED PRACTICE:
QOL among adults with congenital heart disease is
generally good but varies across countries. Most
variation is related to patient characteristics rather
than country-speciﬁc factors. Hence, uniform criteria
can be used across geographical borders to identify
patients facing better or worse QOL outcomes.
TRANSLATIONAL OUTLOOK: More research
should be aimed at deﬁning features of health care
delivery systems in various nations that inﬂuence QOL
among patients with adult CHD.
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2244in-clinic recruitment in most participating centers, it
was not possible to determine precise response rates
or to compare background data from responders and
nonresponders. One exception in this matter was data
coming from Sweden. Eligible patients were selected
from a national registry, and comparison of demo-
graphic and clinical data revealed only small differ-
ences between responders and nonresponders (data
submitted). All continents were represented in the
study, except for Africa. Logistics and limited funding
made it too difﬁcult for African centers to participate.
Furthermore, the care of adult CHD patients is an issue
only in some African countries. Fifth, we were not able
to verify differential item functioning in this study.
Differential item functioning means that people
from different groups (e.g., North American vs. Asian
patients) have a different probability of giving a
certain response on a questionnaire. Differential item
functioning should be an area of scrutiny in future
analyses of international PRO data.
In conclusion, this is the ﬁrst large-scale interna-
tional study comprehensively assessing QOL in
patients with CHD. Overall QOL in adults with CHD
was found to be generally good and QOL varied
across countries. This between-country variation was
related to some patient characteristics, including
age, marital status, employment status, and patient-
reported NYHA functional class assessment.
Country-speciﬁc characteristics, including national
happiness level and cultural dimensions, were not
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